Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 215,257,575 papers from all fields of science
Search
Sign In
Create Free Account
68Ga-DOTA-Arg-Gly-Asp
Known as:
68Ga-DOTA-RGD
, 68Ga-DOTA-arginine-glycine-aspartic acid
, 68Ga-DOTA-arginyl-glycyl-aspartic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Heterocyclic Compounds, 1-Ring
Oligopeptides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Absorbed dose estimates from a single measurement one to three days after the administration of 177Lu-DOTATATE/-TOC
H. Hänscheid
,
C. Lapa
,
A. Buck
,
M. Lassmann
,
R. Werner
Nuklearmedizin
2017
Corpus ID: 3846074
Summary Aim: To retrospectively analyze the accuracy of absorbed dose estimates from a single measurement of the activity…
Expand
2016
2016
The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin
P. Kazmierczak
,
A. Rominger
,
+5 authors
C. Cyran
European Radiology
2016
Corpus ID: 12507623
ObjectivesTo quantify the additional value of 68Ga-DOTA-TATE PET/CT in comparison with contrast-enhanced CT alone for primary…
Expand
2015
2015
Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla
Peter Fries
,
D. Morr
,
+8 authors
Arno Bücker
Fortschritte auf dem Gebiet der Röntgenstrahlen…
2015
Corpus ID: 19763914
Abstract Purpose: The aim of this study was to compare a Gd-based nanoparticle (AGuIX) with a standard extracellular Gd-based…
Expand
Review
2010
Review
2010
Safety of Gadoterate Meglumine (Gd-DOTA) as a Contrast Agent for Magnetic Resonance Imaging
T. Ishiguchi
,
Shoki Takahashi
Drugs in R&D
2010
Corpus ID: 18090167
AbstractBackground: Safety is a primary concern with contrast agents used for MRI. If precautions could be taken before the…
Expand
2010
2010
Comparative evaluation of three 64Cu-labeled E. coli heat-stable enterotoxin analogues for PET imaging of colorectal cancer.
Dijie Liu
,
D. Overbey
,
+6 authors
M. Giblin
Bioconjugate chemistry
2010
Corpus ID: 25984650
Analogues of the E. coli heat-stable enterotoxin (STh) are currently under study as both imaging and therapeutic agents for…
Expand
2009
2009
Positron Emission Tomography Imaging of Poststroke Angiogenesis
W. Cai
,
R. Guzman
,
+14 authors
Xiaoyuan Chen
Stroke
2009
Corpus ID: 7690208
Background and Purpose— Vascular endothelial growth factor (VEGF) and VEGF receptors (VEGFRs) play important roles during…
Expand
2009
2009
Gallium-67-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide for primary and metastatic melanoma imaging.
Haixun Guo
,
Jianquan Yang
,
N. Shenoy
,
Y. Miao
Bioconjugate chemistry
2009
Corpus ID: 27639203
The purpose of this study was to examine the melanoma imaging properties of a novel 67Ga-labeled lactam bridge-cyclized alpha…
Expand
Highly Cited
2005
Highly Cited
2005
Melanoma Therapy via Peptide-Targeted α-Radiation
Y. Miao
,
M. Hylarides
,
+7 authors
T. Quinn
Clinical Cancer Research
2005
Corpus ID: 27701510
Purpose: The therapeutic efficacy of a unique melanoma-targeting peptide conjugated with an in vivo generated α-particle-emitting…
Expand
Highly Cited
2003
Highly Cited
2003
Prospective blinded evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced peripheral MR angiography, as compared with digital subtraction angiography.
R. Wyttenbach
,
S. Gianella
,
M. Alerci
,
A. Braghetti
,
L. Cozzi
,
A. Gallino
Radiology
2003
Corpus ID: 41228660
PURPOSE To compare the diagnostic accuracy of gadobenate dimeglumine (Gd-BOPTA)-enhanced versus gadoterate meglumine (Gd-DOTA…
Expand
1994
1994
Renal Tolerance of Gadolinium-DOTA and Gadolinium-DTPA in Rats
G. Brillet
,
M. Dubois
,
H. Beaufils
,
R. Bourbouze
,
G. Deray
Investigative Radiology
1994
Corpus ID: 44890844
RATIONALE AND OBJECTIVES.Although gadolinium chelates are mainly eliminated by the kidney, there is limited information about…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE